LIVIVO - Search results -

Search results

Result 1 - 10 of total 41

Search options

Article ; Online: Lung-function trajectories: relevance and implementation in clinical practice.

2024 Volume 403, Issue 10435, Page(s) 1494–1503

Abstract: Lung development starts in utero and continues during childhood through to adolescence, reaching its peak in early adulthood. This growth is followed by gradual decline due to physiological lung ageing. Lung-function development can be altered by several ...

Abstract	Lung development starts in utero and continues during childhood through to adolescence, reaching its peak in early adulthood. This growth is followed by gradual decline due to physiological lung ageing. Lung-function development can be altered by several host and environmental factors during the life course. As a result, a range of lung-function trajectories exist in the population. Below average trajectories are associated with respiratory, cardiovascular, metabolic, and mental health comorbidities, as well as with premature death. This Review presents progressive research into lung-function trajectories and assists the implementation of this knowledge in clinical practice as an innovative approach to detect poor lung health early, monitor respiratory disease progression, and promote lung health. Specifically, we propose that, similar to paediatric height and weight charts used globally to monitor children's growth, lung-function charts could be used for both children and adults to monitor lung health status across the life course. To achieve this proposal, we introduce our free online Lung Function Tracker tool. Finally, we discuss challenges and opportunities for effective implementation of the trajectory concept at population level and outline an agenda for crucial research needed to support such implementation.
MeSH term(s)	Adult ; Adolescent ; Child ; Humans ; Lung ; Mental Health ; Health Status ; Respiratory Tract Diseases
Language	English
Publishing date	2024-03-12
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	3306-6
ISSN	1474-547X ; 0023-7507 ; 0140-6736
ISSN (online)	1474-547X
ISSN	0023-7507 ; 0140-6736
DOI	10.1016/S0140-6736(24)00016-3
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.5: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MG 94: Show issues

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: miR-25 in heart failure.

Bush, Erik W / van Rooij, Eva

Circulation research

2014 Volume 115, Issue 7, Page(s) 610–612

MeSH term(s)	Animals ; Heart Failure/genetics ; Heart Failure/therapy ; Humans ; Male ; MicroRNAs/antagonists & inhibitors ; Myocardial Contraction/drug effects
Chemical Substances	MicroRNAs
Language	English
Publishing date	2014-09-12
Publishing country	United States
Document type	Comment ; Journal Article
ZDB-ID	80100-8
ISSN	1524-4571 ; 0009-7330 ; 0931-6876
ISSN (online)	1524-4571
ISSN	0009-7330 ; 0931-6876
DOI	10.1161/CIRCRESAHA.114.304909
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ui IV Zs.70: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Ui IV Zs.60: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Full-Range Public Health Leadership, Part 2: Qualitative Analysis and Synthesis.

Carlton, Erik L / Holsinger, James W / Riddell, Martha C / Bush, Heather

Frontiers in public health

2015 Volume 3, Page(s) 174

Abstract: Public health leadership is an important topic in the era of U.S. health reform, population health innovation, and health system transformation. This study utilized the full-range leadership model in order to examine the public health leadership. We ... ...

Abstract	Public health leadership is an important topic in the era of U.S. health reform, population health innovation, and health system transformation. This study utilized the full-range leadership model in order to examine the public health leadership. We sought to understand local public health leadership from the perspective of local health department leaders and those who work with and for them. Public health leadership was explored through interviews and focus groups with directors (n = 4) and staff (n = 33) from local health departments. Qualitative analytic methods included reflexive journals, code-recode procedures, and member checking, with analysis facilitated by Atlas.ti v.6.0. Qualitative results supported and expanded upon previously reported quantitative findings. Leading by example and providing individual consideration to followers were found to be more important than other leader factors, such as intellectual stimulation, inspirational motivation, or idealized attributes of leaders. Having a clear and competent vision of public health, being able to work collaboratively with other community agencies, and addressing the current challenges to public health with creativity and innovation were also important findings. Idealized leadership behaviors and individual consideration should be the focus of student and professional development. Models that incorporate contextual considerations, such as the situational leadership model, could be utilized to ensure that optimal individual consideration is given to followers.
Language	English
Publishing date	2015-07-08
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2711781-9
ISSN	2296-2565
ISSN	2296-2565
DOI	10.3389/fpubh.2015.00174
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Full-range public health leadership, part 1: quantitative analysis.

Carlton, Erik L / Holsinger, James W / Riddell, Martha / Bush, Heather

Frontiers in public health

2015 Volume 3, Page(s) 73

Abstract: Background: Workforce and leadership development are central to the future of public health. However, public health has been slow to translate and apply leadership models from other professions and to incorporate local perspectives in understanding ... ...

Abstract	Background: Workforce and leadership development are central to the future of public health. However, public health has been slow to translate and apply leadership models from other professions and to incorporate local perspectives in understanding public health leadership. Purpose: This study utilized the full-range leadership model in order to examine public health leadership. Specifically, it sought to measure leadership styles among local health department directors and to understand the context of leadership in local health departments. Methods: Leadership styles among local health department directors (n = 13) were examined using survey methodology. Quantitative analysis methods included descriptive statistics, boxplots, and Pearson bivariate correlations using SPSS v18.0. Findings: Self-reported leadership styles were highly correlated to leadership outcomes at the organizational level. However, they were not related to county health rankings. Results suggest the preeminence of leader behaviors and providing individual consideration to staff as compared to idealized attributes of leaders, intellectual stimulation, or inspirational motivation. Implications: Holistic leadership assessment instruments such as the multifactor leadership questionnaire can be useful in assessing public health leaders' approaches and outcomes. Comprehensive, 360-degree reviews may be especially helpful. Further research is needed to examine the effectiveness of public health leadership development models, as well as the extent that public health leadership impacts public health outcomes.
Language	English
Publishing date	2015-04-30
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2711781-9
ISSN	2296-2565
ISSN	2296-2565
DOI	10.3389/fpubh.2015.00073
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.

Bush, Erik W / McKinsey, Timothy A

Circulation research

2010 Volume 106, Issue 2, Page(s) 272–284

Abstract: Acetylation of histone and nonhistone proteins provides a key mechanism for controlling signaling and gene expression in heart and kidney. Pharmacological inhibition of protein deacetylation with histone deacetylase (HDAC) inhibitors has shown promise in ...

Abstract	Acetylation of histone and nonhistone proteins provides a key mechanism for controlling signaling and gene expression in heart and kidney. Pharmacological inhibition of protein deacetylation with histone deacetylase (HDAC) inhibitors has shown promise in preclinical models of cardiovascular and renal disease. Efficacy of HDAC inhibitors appears to be governed by pleiotropic salutary actions on a variety of cell types and pathophysiological processes, including myocyte hypertrophy, fibrosis, inflammation and epithelial-to-mesenchymal transition, and occurs at compound concentrations below the threshold required to elicit toxic side effects. We review the roles of acetylation/deacetylation in the heart and kidney and provide rationale for extending HDAC inhibitors into clinical testing for indications involving these organs.
MeSH term(s)	Acetylation ; Animals ; Heart Diseases/genetics ; Heart Diseases/metabolism ; Heart Diseases/prevention & control ; Histone Deacetylase Inhibitors/pharmacology ; Histone Deacetylase Inhibitors/therapeutic use ; Histone Deacetylases/metabolism ; Histones/metabolism ; Humans ; Kidney Diseases/genetics ; Kidney Diseases/metabolism ; Kidney Diseases/prevention & control ; Models, Biological ; Protein Processing, Post-Translational
Chemical Substances	Histone Deacetylase Inhibitors ; Histones ; Histone Deacetylases (EC 3.5.1.98)
Language	English
Publishing date	2010-02-05
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	80100-8
ISSN	1524-4571 ; 0009-7330 ; 0931-6876
ISSN (online)	1524-4571
ISSN	0009-7330 ; 0931-6876
DOI	10.1161/CIRCRESAHA.109.209338
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ui IV Zs.70: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Ui IV Zs.60: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).

Khaleva, Ekaterina / Rattu, Anna / Brightling, Chris / Bush, Andrew / Bossios, Apostolos / Bourdin, Arnaud / Chung, Kian Fan / Chaudhuri, Rekha / Coleman, Courtney / Dahlén, Sven-Erik / Djukanovic, Ratko / Deschildre, Antoine / Fleming, Louise / Fowler, Stephen J / Gupta, Atul / Hamelmann, Eckard / Hashimoto, Simone / Hedlin, Gunilla / Koppelman, Gerard H /

Melén, Erik / Murray, Clare S / Pilette, Charles / Porsbjerg, Celeste / Pike, Katharine C / Rusconi, Franca / Williams, Clare / Ahrens, Birgit / Alter, Peter / Anckers, Freja / van den Berge, Maarten / Blumchen, Katharina / Brusselle, Guy / Clarke, Graham W / Cunoosamy, Danen / Dahlén, Barbro / Dixey, Piers / Exley, Andrew / Frey, Urs / Gaillard, Erol A / Giovannini-Chami, Lisa / Grigg, Jonathan / Hartenstein, Diana / Heaney, Liam G / Karadag, Bülent / Kaul, Susanne / Kull, Inger / Licari, Amelia / Maitland-van der Zee, Anke H / Mahler, Vera / Schoos, Ann-Marie M / Nagakumar, Prasad / Negus, Jenny / Nielsen, Hanna / Paton, James / Pijnenburg, Mariëlle / Ramiconi, Valeria / Romagosa Vilarnau, Sofia / Principe, Stefania / Rutjes, Niels / Saglani, Sejal / Seddon, Paul / Singer, Florian / Staudinger, Heribert / Turner, Steve / Vijverberg, Susanne / Winders, Tonya / Yasinska, Valentyna / Roberts, Graham

The European respiratory journal

2023 Volume 61, Issue 4

Abstract: Background: Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Measures sets for paediatric and adult Severe Asthma) Working Group sought to develop Core Outcome Measures (COM) sets to ... ...

Abstract	Background: Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Measures sets for paediatric and adult Severe Asthma) Working Group sought to develop Core Outcome Measures (COM) sets to facilitate better synthesis of data and appraisal of biologics in paediatric and adult asthma clinical studies. Methods: COMSA utilised a multi-stakeholder consensus process among patients with severe asthma, adult and paediatric clinicians, pharmaceutical representatives, and health regulators from across Europe. Evidence included a systematic review of development, validity and reliability of selected outcome measures plus a narrative review and a pan-European survey to better understand patients' and carers' views about outcome measures. It was discussed using a modified GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision framework. Anonymous voting was conducted using predefined consensus criteria. Results: Both adult and paediatric COM sets include forced expiratory volume in 1 s (FEV Conclusions: This patient-centred collaboration has produced two COM sets for paediatric and adult severe asthma. It is expected that they will inform the methodology of future clinical trials, enhance comparability of efficacy and effectiveness of biological therapies, and help assess their socioeconomic value. COMSA will inform definitions of non-response and response to biological therapy for severe asthma.
MeSH term(s)	Child ; Humans ; Adult ; Quality of Life ; Reproducibility of Results ; Disease Progression ; Asthma/drug therapy ; Outcome Assessment, Health Care ; Anti-Asthmatic Agents/therapeutic use
Chemical Substances	Anti-Asthmatic Agents
Language	English
Publishing date	2023-04-03
Publishing country	England
Document type	Systematic Review ; Journal Article ; Review ; Research Support, Non-U.S. Gov't
ZDB-ID	639359-7
ISSN	1399-3003 ; 0903-1936
ISSN (online)	1399-3003
ISSN	0903-1936
DOI	10.1183/13993003.00606-2022
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2322: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 292: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Full-Range Public Health Leadership, Part 2

Erik L. Carlton / James W. Holsinger / Martha C Riddell / Heather eBush

Frontiers in Public Health, Vol

Qualitative Analysis and Synthesis

2015 Volume 3

Abstract: Public health leadership is an important topic in the era of U. S. health reform, population health innovation, and health system transformation. This study utilized the full-range leadership model in order to examine public health leadership. We sought ... ...

Abstract	Public health leadership is an important topic in the era of U. S. health reform, population health innovation, and health system transformation. This study utilized the full-range leadership model in order to examine public health leadership. We sought to understand local public health leadership from the perspective of local health department leaders and those who work with and for them. Public health leadership was explored through interviews and focus groups with directors (n=4) and staff (n=33) from local health departments. Qualitative analytic methods included reflexive journals, code-recode procedures, and member checking, with analysis facilitated by Atlas.ti v.6.0. Qualitative results supported and expanded upon previously reported quantitative findings. Leading by example and providing individual consideration to followers were found to be more important than other leader factors such as intellectual stimulation, inspirational motivation, or idealized attributes of leaders. Having a clear and competent vision of public health, being able to work collaboratively with other community agencies, and addressing the current challenges to public health with creativity and innovation were also important findings. Idealized leadership behaviors and individual consideration should be the focus of student and professional development. Models that incorporate contextual considerations, such as the situational leadership model, should be utilized and instruction in basic interpersonal skills may prove useful. The development of a detailed leadership assessment and development process for public health practitioners is indicated.
Keywords	local health department ; Transformational leadership ; Multifactor Leadership Questionnaire ; Public health leadership ; Full-range leadership ; public health workforce development ; Public aspects of medicine ; RA1-1270
Subject code	360
Language	English
Publishing date	2015-07-01T00:00:00Z
Publisher	Frontiers Media S.A.
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Full-Range Public Health Leadership, Part 1

Erik L. Carlton / James W. Holsinger / Martha eRiddell / Heather eBush

Frontiers in Public Health, Vol

Quantitative Analysis

2015 Volume 3

Abstract: Background. Workforce and leadership development are central to the future of public health. However, public health has been slow to translate and apply leadership models from other professions and to incorporate local perspectives in understanding ... ...

Abstract	Background. Workforce and leadership development are central to the future of public health. However, public health has been slow to translate and apply leadership models from other professions and to incorporate local perspectives in understanding public health leadership. Purpose. This study utilized the full-range leadership model in order to examine public health leadership. Specifically, it sought to measure leadership styles among local health department directors and to understand the context of leadership local health departments.Methods. Leadership styles among local health department directors (n=13) were examined using survey methodology. Quantitative analysis methods included descriptive statistics, boxplots, and Pearson bivariate correlations using SPSS v18.0. Findings. Self-reported leadership styles were highly correlated to leadership outcomes at the organizational level. However, they were not related to county health rankings. Results suggest the preeminence of leader behaviors and providing individual consideration to staff as compared to idealized attributes of leaders, intellectual stimulation, or inspirational motivation. Implications. Holistic leadership assessment instruments, such as the Multifactor Leadership Questionnaire (MLQ) can be useful in assessing public health leaders approaches and outcomes. Comprehensive, 360-degree reviews may be especially helpful. Further research is needed to examine the effectiveness of public health leadership development models, as well as the extent that public health leadership impacts public health outcomes.
Keywords	local health department ; Transformational leadership ; Multifactor Leadership Questionnaire ; Public health leadership ; Full-range leadership ; public health workforce development ; Public aspects of medicine ; RA1-1270
Language	English
Publishing date	2015-04-01T00:00:00Z
Publisher	Frontiers Media S.A.
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Targeting histone deacetylases for heart failure.

Bush, Erik W / McKinsey, Timothy A

Expert opinion on therapeutic targets

2009 Volume 13, Issue 7, Page(s) 767–784

Abstract: Background: Stresses such as chronic hypertension and myocardial infarction can trigger the heart to undergo a remodeling process characterized by myocyte hypertrophy, myocyte death and fibrosis, often resulting in impaired cardiac function and heart ... ...

Abstract	Background: Stresses such as chronic hypertension and myocardial infarction can trigger the heart to undergo a remodeling process characterized by myocyte hypertrophy, myocyte death and fibrosis, often resulting in impaired cardiac function and heart failure. Recent studies suggest key roles for histone deacetylases (HDACs) in the control of pathological cardiac remodeling. Objective/methods: Here, we review these target validation experiments and highlight non-cardiac functions of HDACs that will need to be addressed during development of HDAC-directed therapies for heart failure. Results/conclusions: HDACs are unique and attractive therapeutic targets for heart failure because of their positions far downstream in pathological signaling cascades. Confirmation of the validity and viability of approaches aimed at HDACs awaits in vivo proof-of-concept testing with novel small molecule regulators of these enzymes.
MeSH term(s)	Animals ; Cardiomegaly/drug therapy ; Cardiomegaly/physiopathology ; Drug Delivery Systems ; Drug Design ; Enzyme Inhibitors/pharmacology ; Heart Failure/drug therapy ; Heart Failure/physiopathology ; Histone Deacetylase Inhibitors ; Histone Deacetylases/metabolism ; Humans ; Ventricular Remodeling/drug effects
Chemical Substances	Enzyme Inhibitors ; Histone Deacetylase Inhibitors ; Histone Deacetylases (EC 3.5.1.98)
Language	English
Publishing date	2009-07
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	2055208-7
ISSN	1744-7631 ; 1472-8222
ISSN (online)	1744-7631
ISSN	1472-8222
DOI	10.1517/14728220902939161
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 5244: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.

Lucas, Calixto-Hope G / Sloan, Emily A / Gupta, Rohit / Wu, Jasper / Pratt, Drew / Vasudevan, Harish N / Ravindranathan, Ajay / Barreto, Jairo / Williams, Erik A / Shai, Anny / Whipple, Nicholas S / Bruggers, Carol S / Maher, Ossama / Nabors, Burt / Rodriguez, Michael / Samuel, David / Brown, Melandee / Carmichael, Jason / Lu, Rufei /

Acta neuropathologica

2022 Volume 144, Issue 4, Page(s) 747–765

Abstract: Gliomas arising in the setting of neurofibromatosis type 1 (NF1) are heterogeneous, occurring from childhood through adulthood, can be histologically low-grade or high-grade, and follow an indolent or aggressive clinical course. Comprehensive profiling ... ...

Abstract	Gliomas arising in the setting of neurofibromatosis type 1 (NF1) are heterogeneous, occurring from childhood through adulthood, can be histologically low-grade or high-grade, and follow an indolent or aggressive clinical course. Comprehensive profiling of genetic alterations beyond NF1 inactivation and epigenetic classification of these tumors remain limited. Through next-generation sequencing, copy number analysis, and DNA methylation profiling of gliomas from 47 NF1 patients, we identified 2 molecular subgroups of NF1-associated gliomas. The first harbored biallelic NF1 inactivation only, occurred primarily during childhood, followed a more indolent clinical course, and had a unique epigenetic signature for which we propose the terminology "pilocytic astrocytoma, arising in the setting of NF1". The second subgroup harbored additional oncogenic alterations including CDKN2A homozygous deletion and ATRX mutation, occurred primarily during adulthood, followed a more aggressive clinical course, and was epigenetically diverse, with most tumors aligning with either high-grade astrocytoma with piloid features or various subclasses of IDH-wildtype glioblastoma. Several patients were treated with small molecule MEK inhibitors that resulted in stable disease or tumor regression when used as a single agent, but only in the context of those tumors with NF1 inactivation lacking additional oncogenic alterations. Together, these findings highlight recurrently altered pathways in NF1-associated gliomas and help inform targeted therapeutic strategies for this patient population.
MeSH term(s)	Adult ; Astrocytoma/genetics ; Brain Neoplasms/genetics ; Glioma/genetics ; Glioma/pathology ; Homozygote ; Humans ; Neurofibromatosis 1/complications ; Neurofibromatosis 1/genetics ; Sequence Deletion
Language	English
Publishing date	2022-08-09
Publishing country	Germany
Document type	Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID	1079-0
ISSN	1432-0533 ; 0001-6322
ISSN (online)	1432-0533
ISSN	0001-6322
DOI	10.1007/s00401-022-02478-5
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Ui II Zs.188: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito